Cited by 102Alzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis ResearchDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

C9orf72 Hexanucleotide Repeat Expansions in Clinical Alzheimer Disease

Open access

Harms, Matthew, Benitez, Bruno A., Cairns, Nigel, Cooper, Breanna, Cooper, Paul, Mayo, Kevin, Carrell, David, Faber, Kelley, Williamson, Jennifer, Bird, Tom, Diaz-Arrastia, Ramon, Foroud, Tatiana M., Boeve, Bradley F., Graff-Radford, Neill R., Mayeux, Richard, Chakraverty, Sumitra, Goate, Alison M., Cruchaga, Carlos, NIA-LOAD/NCRAD Family Study Consortium, for the·2013·JAMA Neurology

DOI 10.1001/2013.jamaneurol.537PMC PMC3681841

Open this paper in CoChat — free account

Abstract

IMPORTANCE: Hexanucleotide repeat expansions in the chromosome 9 open reading frame 72 (C9orf72) gene underlie a significant fraction of frontotemporal dementia and amyotrophic lateral sclerosis. OBJECTIVE: To investigate the frequency of C9orf72 repeat expansions in clinically diagnosed late-onset Alzheimer disease (AD). DESIGN, SETTING, AND PATIENTS: This case-control study genotyped the C9orf72 repeat expansion in 872 unrelated familial AD cases and 888 control subjects recruited as part of the National Institute on Aging Late-Onset Alzheimer Disease Family Study cohort, a multisite collaboration studying 1000 families with 2 or more individuals clinically diagnosed as having late-onset AD. MAIN OUTCOMES AND MEASURES: We determined the presence or absence of the C9orf72 repeat expansion by repeat-primed polymerase chain reaction, the length of the longest nonexpanded allele, segregation of the genotype with disease, and clinical features of repeat expansion carriers. RESULTS Three families showed large C9orf72 hexanucleotide repeat expansions. Two additional families carried more than 30 repeats. Segregation with disease could be demonstrated in 3 families. One affected expansion carrier had neuropathology compatible with AD. In the National Institute on Aging Late-Onset Alzheimer Disease Family Study series, the C9orf72 repeat expansions constituted the second most common pathogenic mutation, just behind the PSEN1 A79V mutation, highlighting the heterogeneity of clinical presentations associated with repeat expansions. CONCLUSIONS AND RELEVANCE: C9orf72 repeat expansions explain a small proportion of patients with a clinical presentation indistinguishable from AD, and they highlight the necessity of screening frontotemporal dementia genes in clinical AD cases with strong family history.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/2013.jamaneurol.537

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 14×
“Furthermore, it is not known whether higher repeat numbers (but still within the normal range) are associated with the risk for ALS or FTD.”
BackgroundMethodInfluentialSelf-citation
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Self-citation
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Alzheimer’s Disease: The Challenge of the Second Century
Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002369 · Cited by 1,424
Self-citation
The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity
Hansen, L., Salmon, D., Galasko, D., Masliah, E., Katzman, R., DeTeresa, R., Thal, L., Pay, M. M., Hofstetter, R., Klauber, M., et al. (1990) · Neurology · doi:10.1212/wnl.40.1.1 · Cited by 1,068
Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease: Relation of Histologic Markers to Dementia Severity, Age, Sex, and Apolipoprotein E Genotype
Berg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.326 · Cited by 657
Self-citation
Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72
Boeve, B. F., Boylan, K., Graff‐Radford, N. R., DeJesus‐Hernandez, M., Knopman, D. S., Pedraza, O., Vemuri, P., Jones, D. T., Lowe, V. J., Murray, M. E., et al. (2012) · Brain · doi:10.1093/brain/aws004 · Cited by 351
Self-citation
Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer’s disease families
Cruchaga, C., Chakraverty, S., Mayo, K., Vallania, F. L. M., Mitra, R. D., Faber, K., Williamson, J., Bird, T., Diaz-Arrastia, R., Foroud, T. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031039 · Cited by 320
Self-citation
Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72
Murray, M. E., DeJesus‐Hernandez, M., Rutherford, N. J., Baker, M. C., Duara, R., Graff‐Radford, N. R., Wszołek, Z. K., Ferman, T. J., Josephs, K. A., Boylan, K., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0907-y · Cited by 301
Self-citation

Show all 33 references

Research works printed but not linked: 1

[16]Cruchaga C Chakraventy S Mayo K Vallania FL Mitra A Faber KM Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer’s Disease families PLoS One 2012 In Press. PMC3270040 22312439

Sorted by citations

Defeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00062-4 · Cited by 1,676
Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
Sareen, D., O’Rourke, J. G., Meera, P., Muhammad, A. K. M. G., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007529 · Cited by 670
Self-citation
Molecular genetics of early-onset Alzheimer’s disease revisited
Cacace, R., Sleegers, K., & Van Broeckhoven, C. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.01.012 · Cited by 617
Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease
Cruchaga, C., Karch, C. M., Jin, S. C., Benitez, B. A., Cai, Y., Guerreiro, R., Harari, O., Norton, J., Budde, J., Bertelsen, S., et al. (2014) · Nature · doi:10.1038/nature12825 · Cited by 461
Self-citation
Interactions of pathological proteins in neurodegenerative diseases
Spires‐Jones, T. L., Attems, J., & Thal, D. R. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1709-7 · Cited by 435
Association of Brain DNA Methylation in SORL1,ABCA7,HLA-DRB5,SLC24A4, and BIN1 With Pathological Diagnosis of Alzheimer Disease
Yu, L., Chibnik, L. B., Srivastava, G. P., Pochet, N., Yang, J., Xu, J., Kozubek, J., Obholzer, N., Leurgans, S. E., Schneider, J. A., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.3049 · Cited by 290
The biological pathways of Alzheimer disease: a review
Calabrò, M., Rinaldi, C., Santoro, G., & Crisafulli, C. (2020) · AIMS neuroscience · doi:10.3934/neuroscience.2021005 · Cited by 287
Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine
Irwin, D. J., Cairns, N. J., Grossman, M., McMillan, C. T., Lee, E. B., Deerlin, V. M. V., Lee, V. M. ‐., & Trojanowski, J. Q. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1380-1 · Cited by 278
Self-citation
C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis
Rohrer, J. D., Isaacs, A. M., Mizielinska, S., Mead, S., Lashley, T., Wray, S., Sidle, K. C. L., Fratta, P., Orrell, R. W., Hardy, J., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70233-9 · Cited by 255
R Loops and Links to Human Disease
Richard, P., & Manley, J. L. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.08.031 · Cited by 230
Autophagy and ALS: mechanistic insights and therapeutic implications
Chua, J. P., De Calbiac, H., Kabashi, E., & Barmada, S. J. (2022) · Autophagy · doi:10.1080/15548627.2021.1926656 · Cited by 189
Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72
Mann, D. M., Rollinson, S., Robinson, A., Bennion Callister, J., Thompson, J. C., Snowden, J. S., Gendron, T., Petrucelli, L., Masuda-Suzukake, M., Hasegawa, M., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-68 · Cited by 182
C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD
Liu, E. Y., Russ, J., Wu, K., Neal, D., Suh, E., McNally, A. G., Irwin, D. J., Van Deerlin, V. M., & Lee, E. B. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1286-y · Cited by 180
The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype
Cooper‐Knock, J., Shaw, P. J., & Kirby, J. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1251-9 · Cited by 169
A rare mutation in UNC5C predisposes to late-onset Alzheimer's disease and increases neuronal cell death
Alzheimer's Disease Genetics Consortium, Wetzel-Smith, M. K., Hunkapiller, J., Bhangale, T. R., Srinivasan, K., Maloney, J. A., Atwal, J. K., Sa, S. M., B Yaylaoglu, M., Foreman, O., et al. (2014) · Nature Medicine · doi:10.1038/nm.3736 · Cited by 153
Self-citation
C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly
Wang, T., Liu, H., Itoh, K., Oh, S., Zhao, L., Murata, D., Sesaki, H., Härtung, T., Na, C. H., & Wang, J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.005 · Cited by 154
C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation
Lall, D., Lorenzini, I., Mota, T. A., Bell, S., Mahan, T. E., Ulrich, J. D., Davtyan, H., Rexach, J. E., Muhammad, A. K. M. G., Shelest, O., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.05.020 · Cited by 147
Polygenic risk score of sporadic late‐onset Alzheimer's disease reveals a shared architecture with the familial and early‐onset forms
Cruchaga, C., Del‐Aguila, J. L., Saef, B., Black, K., Fernandez, M. V., Budde, J., Ibanez, L., Deming, Y., Kapoor, M., Tosto, G., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.08.013 · Cited by 138
Self-citation
Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier
Russ, J., Liu, E. Y., Wu, K., Neal, D., Suh, E. R., Irwin, D. J., McMillan, C. T., Harms, M. B., Cairns, N. J., Wood, E. M., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1365-0 · Cited by 127
Self-citation
Relationship between C9orf72 repeat size and clinical phenotype
Mossevelde, S. V., van der Zee, J., Cruts, M., & Broeckhoven, C. V. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.02.008 · Cited by 128
Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia
Benussi, A., Padovani, A., & Borroni, B. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00171 · Cited by 129
Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72
Davidson, Y. S., Barker, H., Robinson, A., Thompson, J. C., Harris, J., Troakes, C., Smith, B. N., Al‐Saraj, S., Shaw, C. E., Rollinson, S. J., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-70 · Cited by 120
Distinct molecular patterns of TDP-43 pathology in Alzheimer’s disease: relationship with clinical phenotypes
Tomé, S. O., Vandenberghe, R. R., Ospitalieri, S., Schoor, E. V., Tousseyn, T., Otto, M., Arnim, C. A. F. V., & Thal, D. R. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00934-5 · Cited by 105
In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers
DeJesus‐Hernandez, M., Finch, N. A., Wang, X., Gendron, T. F., Bieniek, K. F., Heckman, M. G., Vasilevich, A. S., Murray, M. E., Rousseau, L., Weesner, R. E., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1725-7 · Cited by 94
Self-citation
Genotype–phenotype links in frontotemporal lobar degeneration
Mossevelde, S. V., Engelborghs, S., van der Zee, J., & Broeckhoven, C. V. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0009-8 · Cited by 94
Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels
Ibáñez, L., Dube, U., Saef, B. A., Budde, J., Black, K., Medvedeva, A., Del‐Aguila, J. L., Davis, A. A., Perlmutter, J. S., Harari, O., et al. (2017) · BMC Neurology · doi:10.1186/s12883-017-0978-z · Cited by 85
Self-citation
Genome-wide analysis of genetic predisposition to Alzheimer’s disease and related sex disparities
Nazarian, A., Yashin, A. I., & Kulminski, A. M. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0458-8 · Cited by 82
Lack of C9ORF72 coding mutations supports a gain of function for repeat expansions in amyotrophic lateral sclerosis
Harms, M. B., Cady, J., Zaidman, C. M., Cooper, P., Bali, T., Allred, P., Cruchaga, C., Baughn, M. W., Libby, R. T., Pestronk, A., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.006 · Cited by 76
Self-citation
Polymerase chain reaction and Southern blot-based analysis of the C9orf72 hexanucleotide repeat in different motor neuron diseases
Hübers, A., Marroquin, N., Schmoll, B., Vielhaber, S., Just, M., Mayer, B., Högel, J., Dorst, J., Mertens, T., Just, W., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.034 · Cited by 69
Recent Advances in the Genetics of Frontotemporal Dementia
Sirkis, D. W., Geier, E. G., Bonham, L. W., Karch, C. M. M., & Yokoyama, J. S. (2019) · Current Genetic Medicine Reports · doi:10.1007/s40142-019-0160-6 · Cited by 71
Update on amyotrophic lateral sclerosis genetics
Brenner, D., & Weishaupt, J. H. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000737 · Cited by 65
Mutational analysis in early-onset familial Alzheimer's disease in Mainland China
Jiao, B., Tang, B., Liu, X., Xu, J. L., Wang, Y., Zhou, L., Zhang, F., Yan, X., Zhou, Y., & Shen, L. H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.014 · Cited by 64
The C9ORF72 expansion mutation: gene structure, phenotypic and diagnostic issues
Woollacott, I., & Mead, S. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1253-7 · Cited by 63
Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat Expansion
Mossevelde, S. V., van der Zee, J., Gijselinck, I., Sleegers, K., Bleecker, J. D., Sieben, A., Vandenberghe, R. R., Langenhove, T. V., Baets, J., Deryck, O., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4847 · Cited by 62
Screening a UK amyotrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansion
Fratta, P., Polke, J. M., Newcombe, J., Mizielinska, S., Lashley, T., Poulter, M., Beck, J. A., Preza, E., Devoy, A., Sidle, K. C. L., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.037 · Cited by 65
Antisense Oligonucleotide Therapy for the Treatment of C9ORF72 ALS/FTD Diseases
Riboldi, G. M., Zanetta, C., Ranieri, M., Nizzardo, M., Simone, C., Magri, F., Bresolin, N., Comi, G. P., & Corti, S. P. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8724-7 · Cited by 57
C9orf72 and its Relevance in Parkinsonism and Movement Disorders: A Comprehensive Review of the Literature
Bourinaris, T., & Houlden, H. (2018) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12677 · Cited by 58
The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis
Cooper‐Knock, J., Kirby, J., Highley, J. R., & Shaw, P. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0342-1 · Cited by 58
Unravelling the clinical spectrum and the role of repeat length in C9ORF72 repeat expansions
van der Ende, E. L., Jackson, J. L., White, A. E., Seelaar, H., van Blitterswijk, M., & Swieten, J. C. V. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325377 · Cited by 52
The analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism
Schottlaender, L., Polke, J. M., Ling, H., MacDoanld, N. D., Tucci, A., Nanji, T., Pittman, A. M., de Silva, R., Holton, J. L., Révész, T., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.08.024 · Cited by 49
Neuronal VCP loss of function recapitulates FTLD-TDP pathology
Wani, A., Zhu, J., Ulrich, J. D., Eteleeb, A. M., Sauerbeck, A. D., Reitz, S. J., Arhzaouy, K., Ikenaga, C., Yuede, C. M., Pittman, S. K., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109399 · Cited by 39
Self-citation
Parkinson disease is not associated with C9ORF72 repeat expansions
Harms, M. B., Neumann, D. A., Benítez, B. A., Cooper, B., Carrell, D., Racette, B. A., Perlmutter, J. S., Goate, A., & Cruchaga, C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.001 · Cited by 43
Self-citation
The role of C9orf72 in neurodegenerative disorders: a systematic review, an updated meta-analysis, and the creation of an online database
Marogianni, C., Rikos, D., Provatas, A., Dadouli, K., Ntellas, P., Tsitsi, P., Patrinos, G. P., Dardiotis, E., Hadjigeorgiou, G. M., & Xiromerisiou, G. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.04.012 · Cited by 41
Clinical Neurogenetics
Harms, M. B., & Baloh, R. H. (2013) · Neurologic Clinics · doi:10.1016/j.ncl.2013.05.003 · Cited by 43
Self-citation
A neuroimaging biomarker for Individual Brain-Related Abnormalities In Neurodegeneration (IBRAIN): a cross-sectional study
Zhao, K., Chen, P., Alexander‐Bloch, A. F., Wei, Y., Dyrba, M., Yang, F., Kang, X., Wang, D., Fan, D., Shan, Y., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102276 · Cited by 38
Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease
Fernández, M. V., Kim, J. H., Budde, J., Black, K., Medvedeva, A., Saef, B. A., Deming, Y. K., Del‐Aguila, J. L., Ibáñez, L., Dube, U., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1007045 · Cited by 35
Self-citation
C9ORF72 Mutations in Neurodegenerative Diseases
Liu, Y., Yu, J., Zong, Y., Zhou, J., & Tan, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8528-1 · Cited by 36
The autophagy of stress granules
Ryan, L., & Rubinsztein, D. C. (2023) · FEBS Letters · doi:10.1002/1873-3468.14787 · Cited by 32
Emerging role of RNA•DNA hybrids inC9orf72-linked neurodegeneration
Wang, J., Haeusler, A. R., & Simko, E. A. J. (2015) · Cell Cycle · doi:10.1080/15384101.2014.995490 · Cited by 31
Absence of C9ORF72 expanded or intermediate repeats in autopsy‐confirmed Parkinson's disease
Nuytemans, K., Inchausti, V., Beecham, G. W., Wang, L., Dickson, D. W., Trojanowski, J. Q., Lee, V. M. ‐., Mash, D. C., Frosch, M. P., Foroud, T., et al. (2014) · Movement Disorders · doi:10.1002/mds.25838 · Cited by 28
Self-citation
C9orf72-related disorders: expanding the clinical and genetic spectrum of neurodegenerative diseases
de Souza, P. V. S., Pinto, W. B. V. D. R., & Oliveira, A. S. B. (2015) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20140229 · Cited by 26
The role of structural variations in Alzheimer’s disease and other neurodegenerative diseases
Wang, H., Wang, L., Schellenberg, G. D., & Lee, W. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1073905 · Cited by 28
The clinical and pathological phenotypes of frontotemporal dementia with C9ORF72 mutations
Liu, Y., Yu, J., Sun, F.-R., Ou, J.-R., Qu, S.-B., & Tan, L. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.09.013 · Cited by 27
C9orf72-Related Neurodegenerative Diseases: From Clinical Diagnosis to Therapeutic Strategies
Zampatti, S., Peconi, C., Campopiano, R., Gambardella, S., Caltagirone, C., & Giardina, E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.907122 · Cited by 22
C9orf72/ALFA-1 controls TFEB/HLH-30-dependent metabolism through dynamic regulation of Rag GTPases
Ji, Y. J., Ugolino, J., Zhang, T., Lu, J., Kim, D., & Wang, J. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008738 · Cited by 22
The National Institute on Aging Late‐Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery
Reyes‐Dumeyer, D., Faber, K. M., Vardarajan, B. N., Goate, A., Renton, A. E., Chao, M., Boeve, B. F., Cruchaga, C., Pericak‐Vance, M. A., Haines, J. L., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12514 · Cited by 17
Self-citation
Familial benign frontotemporal deterioration with C9ORF72 hexanucleotide expansion
Gómez‐Tortosa, E., Serrano, S., de Toledo, M., Pérez‐Pérez, J., & Sainz, M. J. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.09.013 · Cited by 18
The Association between C9orf72 Repeats and Risk of Alzheimer’s Disease and Amyotrophic Lateral Sclerosis: A Meta-Analysis
Li, S., Sun, Q., Zhang, Y., Xu, Q., Guo, J., Yan, X., & Tang, B. (2016) · Parkinson s Disease · doi:10.1155/2016/5731734 · Cited by 18
C9orf72 hexanucleotide repeat length in older population: normal variation and effects on cognition
Kaivola, K., Kiviharju, A., Jansson, L., Rantalainen, V. J., Eriksson, J. G., Strandberg, T. E., Laaksovirta, H., Renton, A. E., Traynor, B. J., Myllykangas, L., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.02.026 · Cited by 17
Excess of rare coding variants in PLD3 in late- but not early-onset Alzheimer’s disease
Schulte, E. C., Kurz, A., Alexopoulos, P., Hampel, H. J., Peters, A., Gieger, C., Rujescu, D., Diehl‐Schmid, J., & Winkelmann, J. (2015) · Human Genome Variation · doi:10.1038/hgv.2014.28 · Cited by 17
DNA Sequence Analysis in Clinical Medicine, Proceeding Cautiously
Smith, M. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00024 · Cited by 17
A familial frontotemporal dementia associated with C9orf72 repeat expansion and dysplastic gangliocytoma
Ferrari, R., Kero, M., Mok, K. Y., Paetau, A. E., Tienari, P. J., Tynninen, O., Hardy, J., Momeni, P., Verkkoniemi‐Ahola, A., & Myllykangas, L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.021 · Cited by 15
Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies
Kun‐Rodrigues, C., Ross, O. A., Orme, T., Shepherd, C. E., Parkkinen, L., Darwent, L., Hernandez, D. G., Ansorge, O., Clark, L. N., Honig, L. S., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.023 · Cited by 15
Self-citation
Concordance Between 11 C-PIB-PET and Clinical Diagnosis in a Memory Clinic
Patricio, C. M., Cohen, G., Russo, J., Suarez, M. F., Nahas, F., Russo, G., Claudio, W., Santiago, P., Leonardo, T., Jorge, C., et al. (2015) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317515576387 · Cited by 13
Intrafamilial Phenotypic Variability in the C9orf72 Gene Expansion: 2 Case Studies
Foxe, D., Elan, E., Burrell, J. R., Leslie, F. V. C., Devenney, E. M., Kwok, J. B., Halliday, G. M., Hodges, J. R., & Piguet, O. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.01615 · Cited by 13
Pathological assessments for the presence of hexanucleotide repeat expansions in C9ORF72 in Alzheimer’s disease
Davidson, Y. S., Robinson, A., Snowden, J. S., & Mann, D. M. A. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-50 · Cited by 11
Cell-type specific differences in promoter activity of the ALS-linked C9orf72 mouse ortholog
Langseth, A. J., Kim, J., Ugolino, J., Shah, Y., Hwang, H., Wang, J., Bergles, D. E., & Brown, S. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-05864-2 · Cited by 13
Distinct neurological disorders with C9orf72 mutations: genetics, pathogenesis, and therapy
Chi, S., Jiang, T., Tan, L., & Yu, J. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.033 · Cited by 12
Insights into disease mechanisms and potential therapeutics for C9orf72-related amyotrophic lateral sclerosis/frontotemporal dementia
Gagliardi, D., Costamagna, G., Taiana, M. M., Andreoli, L., Biella, F., Bersani, M., Bresolin, N., Comi, G. P., & Corti, S. P. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101172 · Cited by 11
Artificial Intelligence-Assisted Comparative Analysis of the Overlapping Molecular Pathophysiology of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia
Wei, Z., Iyer, M. R., Zhao, B., Deng, J., & Mitchell, C. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413450 · Cited by 10
Loss of C9orf72 in Microglia Drives Neuronal Injury by Enhancing Synaptic Pruning in Aged and Alzheimer’s Disease Mice
Wang, M., Jiang, Y., & Huang, Z. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00796-4 · Cited by 9
C9orf72 repeat length might influence clinical sub-phenotypes in dementia patients
König, T., Wurm, R., Parvizi, T., Silvaieh, S., Hotzy, C., Çetin, H., Klotz, S., Gelpí, E., Bancher, C., Benke, T., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105927 · Cited by 11
Frontotemporal lobar dementia and amyotrophic lateral sclerosis associated with c9orf72 expansion
Ber, I. L. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.04.004 · Cited by 8
Genetic correlation and gene-based pleiotropy analysis for four major neurodegenerative diseases with summary statistics
Qiao, J., Wang, T., Shao, Z., Zhu, Y., Zhang, M., Huang, S., & Zeng, P. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.12.012 · Cited by 8
C9orf72 Hexanucleotide Repeat Analysis in Cases with Pathologically Confirmed Dementia with Lewy Bodies
Geiger, J. T., Arthur, K. C., Dawson, T. M., Rosenthal, L. S., Pantelyat, A. Y., Albert, M., Hillis, A. E., Crain, B. J., Pletniková, O., Troncoso, J. C., et al. (2016) · Neurodegenerative Diseases · doi:10.1159/000445872 · Cited by 8
Genetics of dementia in a Finnish cohort
Pasanen, P., Myllykangas, L., Pöyhönen, M., Kiviharju, A., Siitonen, M., Hardy, J., Brás, J., Paetau, A. E., Tienari, P. J., Guerreiro, R. J., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0117-3 · Cited by 11
Clinical Update on C9orf72: Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, and Beyond
Saracino, D., & Ber, I. L. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_5 · Cited by 7
Clinical and genetic characteristics in a central-southern Chinese cohort of early-onset Alzheimer's disease
Liang, Z., Wu, Y., Li, C., & Liu, Z. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1119326 · Cited by 7
Young Onset Alzheimer’s Disease Associated with C9ORF72 Hexanucleotide Expansion: Further Evidence for a Still Unsolved Association
Vinceti, G., Gallingani, C., Zucchi, E., Martinelli, I., Gianferrari, G., Simonini, C., Bedin, R., Chiari, A., Zamboni, G., & Mandrioli, J. (2023) · Genes · doi:10.3390/genes14040930 · Cited by 8
C9ORF72 Gene GGGGCC Hexanucleotide Expansion: A High Clinical Variability from Amyotrophic Lateral Sclerosis to Frontotemporal Dementia
Zubizarreta, I. K., Manero-Azua, Á., Afonso-Agüera, J., & de Nanclares, G. P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13091396 · Cited by 8
Phenotypic variability and neuropsychological findings associated with C9orf72 repeat expansions in a Bulgarian dementia cohort
Mehrabian, S., Thonberg, H., Raycheva, M. R., Lilius, L., Stoyanova, K., Forsell, C., Cavallin, L., Nesheva, D. V., Westman, E., Toncheva, D. I., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208383 · Cited by 6
Intervention of next-generation sequencing in diagnosis of Alzheimer’s disease: challenges and future prospects
Chandy, T. (2023) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2022-0025 · Cited by 4
Meta-analysis of the association between C9orf72 repeats and neurodegeneration diseases
Jin, P., Li, Y., & Li, Y. (2024) · Journal of Neurogenetics · doi:10.1080/01677063.2024.2343672 · Cited by 4
A Case with Early Onset Alzheimer’s Disease, Frontotemporal Hypometabolism, ApoE Genotype ɛ4/ɛ4 and C9ORF72 Intermediate Expansion: A Treviso Dementia (TREDEM) Registry Case Report
Gallucci, M., Dell’Acqua, C., Bergamelli, C., Fenoglio, C., Serpente, M., Galimberti, D., Fiore, V., Medea, S., Gregianin, M., & Battista, M. E. D. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180715 · Cited by 4
The mTORC2/AKT/VCP axis is associated with quality control of the stalled translation of poly(GR) dipeptide repeats in C9-ALS/FTD
Li, Y., Geng, J., Rimal, S., Wang, H., Liu, X., Lu, B., & Li, S. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.102995 · Cited by 4
Early-onset Alzheimer’s disease versus frontotemporal dementia: resolution with genetic diagnoses?
Sha, S. J., Khazenzon, A. M., Ghosh, P. M., Rankin, K. P., Pribadi, M., Coppola, G., Geschwind, D. H., Rabinovici, G. D., Miller, B. L., & Lee, S. E. (2015) · Neurocase · doi:10.1080/13554794.2015.1080283 · Cited by 3
Interrelationship between the Levels of C9orf72 and Amyloid-β Protein Precursor and Amyloid-β in Human Cells and Brain Samples
Leskelä, S., Takalo, M., Marttinen, M., Huber, N., Paananen, J., Mitra, V., Rauramaa, T. H., Mäkinen, P. M., Leinonen, V., Soininen, H. S., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170362 · Cited by 3
Clinical and neuroimaging profiles to identify C9orf72‐FTD patients and serum Neurofilament to monitor the progression and the severity of the disease
Lucidi, G., Berti, V., Piaceri, I., Ginestroni, A., Lombardi, G., Ferrari, C., Polito, C., Bessi, V., Pupi, A., Nacmias, B., et al. (2019) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12331 · Cited by 2
From the Genetic Code to Neuromics
Rosenberg, R. N. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.2854 · Cited by 1
Non‐Alzheimer's amnestic mild cognitive impairment with medial temporal hypometabolism
Keersmaecker, S. D., Meyer, S. D., & Vandenberghe, R. R. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70018 · Cited by 1
C9ORF72 repeat expansion: a genetic mutation associated with Amyotrophic Lateral Sclerosis
Vats, K., Verma, M., Gourie‐Devi, M., & Taneja, V. (2014) · Current Medicine Research and Practice · doi:10.1016/j.cmrp.2014.07.002 · Cited by 2
C9ORF72: grabbing a tiger by the tail
Mann, D. M. A. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1252-8 · Cited by 1
Diversity of Cognitive Phenotypes Associated with C9ORF72 Hexanucleotide Expansion
Gómez‐Tortosa, E., Jurczynska, C. P., Serrano, S., Macías, E. F., Olivié, L., Gallego, J., Guerrero, R., Trujillo-Tiebas, M. J., Ayuso, C., Ruiz, P., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150922 · Cited by 1
Utilidad de la neuroimagen amiloidea en Neurología asistencial
Méndez, P. C., Cohen, G., Russo, M. J., Suarez, M. F., Nahas, F., Russo, G., Claudio, W., Paz, S., Leonardo, T., Campos, J., et al. (2014) · Neurología Argentina · doi:10.1016/j.neuarg.2014.02.003 · Cited by 1
Étude LENSLA : caractérisation des patients atteints de sclérose latérale amyotrophique évoluant depuis plus de 5 ans suivis au centre de référence de Bordeaux
Coignion, C. (2014) · HAL
[Studies on specific stains in paraproteinemia. I. Myeloma].
SEMPRINI, A., Valora, N., Rizza, O., Gf, M., & Bolognesi, G. (1963) · PubMed
Pesquisa da mutação C9ORF72 e de suas características clínicas nos pacientes portadores de esclerose lateral amiotrófica, demência frontotemporal e parkinsonismo atípico
de Oliveira, D. S. (2017) · doi:10.11606/d.17.2017.tde-30032017-135422
Genome-wide association study for adverse reactions of antiepileptic drugs in Korean epilepsy patients
김소원 (2014)
Early-Onset Alzheimer’s Disease, APOE4 And C9orf72 Expansion: A Case Report
Enrique-Benedito, T., Senoret, V., Sanchis, M., Penacho, V., Caracuel, Z., Arrizabalaga, M., Campoy, M. B., & Alcaraz, L. A. (2024) · Annals of Case Reports · doi:10.29011/2574-7754.101812
Frontotemporal dementia: Clinical aspects, genetics, and neuropathology of a family with a C9ORF72 expansion in Argentina
Román, K. D., Cristalli, C. A. A., Surace, E. I., Mezmezian, M. B., Levy, A., Lovera, A. B., Turizo, C. R. C., Sorbara, M., y Rojas, M. M. E., Graviotto, H. G., et al. (2026) · Brain Pathology · doi:10.1111/bpa.70057

Authors: Harms, M., Benitez, B. A., Cairns, N., Cooper, B., Cooper, P., Mayo, K., Carrell, D., Faber, K., Williamson, J., Bird, T., Diaz-Arrastia, R., Foroud, T. M., Boeve, B. F., Graff-Radford, N. R., Mayeux, R., Chakraverty, S., Goate, A. M., Cruchaga, C., & NIA-LOAD/NCRAD Family Study Consortium, F. T.
Affiliations: Washington University in St. Louis (US)
Indiana University Indianapolis (US)
Columbia University (US)
University of Washington (US)
The University of Texas Southwestern Medical Center (US)
Mayo Clinic (US)
Corresponding author: Cruchaga, Carlos
ORCID: Harms, Matthew
Cairns, Nigel
Carrell, David
Faber, Kelley
Diaz-Arrastia, Ramon
Foroud, Tatiana M.
Boeve, Bradley F.
Mayeux, Richard
Goate, Alison M.
Cruchaga, Carlos
Venue: JAMA Neurology
Publisher: American Medical Association (AMA)
Published: 2013-06-01
Volume: 70
Issue: 6
Pages: 736
ISSN: 2168-6149 (ISSN-L)
DOI: 10.1001/2013.jamaneurol.537
PMC: PMC3681841
OpenAlex: W2035247606
Cited by: 102
References: 33
Citations by year: 2026: 1 · 2024: 4 · 2023: 8 · 2022: 4 · 2021: 7 · 2020: 4 · 2019: 9 · 2018: 6 · 2017: 10 · 2016: 8 · 2015: 9 · 2014: 19 · 2013: 11
FWCI: 10.88
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: JAMA Neurology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (5p30ns069329-02)
National Institute on Aging (P50‐AG16574, U01AG06786, U01AG006786, R01 AG32306, R01AG035083, R01AG041797, P50AG008702, R01AG032306, P50AG005681, P30AG013846, P50AG005134, U24AG056270, U24AG021886, P30AG062421, P50AG016574)
National Institute of Mental Health (R01MH060009)
National Institute of Neurological Disorders and Stroke (P30-NS069329, K08NS075094)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: C9orf72, hexanucleotide repeat expansion, late-onset Alzheimer's disease, familial Alzheimer's disease, frontotemporal dementia, amyotrophic lateral sclerosis, genetic susceptibility, genetic screening, neuropathology
MeSH terms: C9orf72 Protein, Adult, Aged, Aged, 80 and over, Alzheimer Disease, Female, Humans, Male, Middle Aged, Pedigree, Proteins, Cohort Studies, Case-Control Studies, DNA Repeat Expansion

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

C9orf72 Hexanucleotide Repeat Expansions in Clinical Alzheimer Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks